Article
Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.
Cancer research - 1 Sept 1996
Han Y, Caday C G, Nanda A, Cavenee W K, Huang H J
Abstract excerpt
The effects of a new epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, tyrphostin AG 1478, were tested on three related human glioma cell lines: U87MG, which expressed endogenous wild-type (wt) EGFR, and two retrovirally infected U87MG cell populations which over-expressed either...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
